Home/Products /rivaroxaban-15-mg-tablet

Rivaroxaban 15mg Tablet in PCD pharma franchise in Hyderabad

Name: Rivaroxaban 15 mg tablet
Brand: Rivaroxaban 15 mg tablet
Rating: 4.8 (150 reviews)

Rivaroxaban 15mg Tablet in pharmaceutical manufacturing company in Mumbai

Rivaroxaban 15mg Tablet in anticoagulant pharma franchise in Pune

Rivaroxaban 15mg Tablet in pharma suppliers in Delhi

Rivaroxaban 15mg Tablet in pharma export companies in Kolkata

Rivaroxaban 15mg Tablet in pharma franchise opportunities in Bengaluru

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Stimulant

Urology

Rivaroxaban 15mg Tablet | Anticoagulant Segment | Best Price for PCD Pharma Franchise

Rivaroxaban 15mg Tablet | Stroke & DVT Prevention | Best Price from Third-Party Manufacturers in India

Rivaroxaban 15mg Tablet | Oral Anticoagulant | Best Price from Pharma Export Companies in India

Rivaroxaban 15mg Tablet | Cardiovascular & Antithrombotic Care | Best Price from Top Pharma Company

Rivaroxaban 15mg Tablet | Direct Factor Xa Inhibitor | Best Price in Cardiac Care Franchise

Rivaroxaban 15 mg tablet

Composition : Rivaroxaban 15 mg tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10x14

Price : ₹1/-

Please Contact For Best Price

Rivaroxaban 15 Tablet is a direct oral anticoagulant (DOAC) that inhibits Factor Xa, a crucial enzyme in the coagulation process. This action helps in preventing the formation of harmful blood clots. The 15 mg strength is typically used in the initial phase of treatment for deep vein thrombosis (DVT) and pulmonary embolism (PE), and provides rapid anticoagulant effect with a fixed dosing schedule. It offers a reliable alternative to traditional vitamin K antagonists, without the need for frequent INR monitoring.

About the Product

The most common adverse effect is bleeding, which may present as easy bruising, nosebleeds, or gastrointestinal bleeding. Other side effects can include nausea, dizziness, or headache. Rare but serious effects may include hepatic dysfunction or allergic reactions. Patients with renal or hepatic impairment should use caution.

Rivaroxaban 15 mg Tablet is indicated for the initial treatment of acute deep vein thrombosis (DVT) and pulmonary embolism (PE). It may also be prescribed in combination with the 20 mg dose for continued therapy in select patients. The use should be guided by a physician experienced in managing thromboembolic disorders.

This medication must be taken exactly as prescribed. It is contraindicated in patients with active bleeding, significant liver disease, or severe renal impairment. Patients should not discontinue Rivaroxaban abruptly without medical advice, as this may increase the risk of thrombotic events. Concurrent use with other anticoagulants or NSAIDs should be monitored closely due to increased bleeding risk.

Store at a temperature below 30°C, away from moisture and direct sunlight. Keep out of reach of children.